financetom
Business
financetom
/
Business
/
TRX Gold Up 3.4% in US Pre-Market Trading as Swings to Fiscal Q2 Profit YoY, Advances Plant Expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TRX Gold Up 3.4% in US Pre-Market Trading as Swings to Fiscal Q2 Profit YoY, Advances Plant Expansion
Apr 15, 2024 5:28 AM

07:45 AM EDT, 04/15/2024 (MT Newswires) -- TRX Gold ( TRX ) was up 3.4% in US pre-market on Monday after reporting net earnings of $1.9 million in the second quarter of its fiscal year, swinging from a year-ago loss of $50,000.

The company's shares dropped 9.7% on Friday in Canada.

Revenue fell to $8 million from $10.1 million while adjusted EBITDA dropped to $2.5 million from $3.9 million.

Meanwhile, TRX said it expects significant growth in throughput and production as it advances the plant expansion at the Buckreef operation to 2,000 tonnes per day (tpd).

The company said the expansion is progressing on schedule, with first gold expected early in the fourth quarter.

TRX also expects to commence an exploration program in the fourth quarter that will include diamond drilling and reverse circulation drilling targeting the Buckreef Main Zone, Eastern porphyry and the Anfield area.

"The Buckreef gold project continues to demonstrate robust economics through its high-margin gold production, in what seems to be an increasingly bullish gold market environment," CEO Stephen Mullowney said. "We very much look forward to doubling plant throughput capacity to 2,000 tpd and ramping up a comprehensive exploration program later this year."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stifel Financial's Q1 Non-GAAP Earnings, Revenue Rise
Stifel Financial's Q1 Non-GAAP Earnings, Revenue Rise
Apr 24, 2024
09:00 AM EDT, 04/24/2024 (MT Newswires) -- Stifel Financial ( SF ) reported Q1 non-GAAP earnings Wednesday of $1.49 per diluted share, up from $1.40 a year earlier. Analysts polled by Capital IQ expected $1.43. Revenue for the quarter ended March 31 was $1.16 billion, up from $1.11 billion a year earlier. Analysts surveyed by Capital IQ expected $1.14 billion....
Sector Update: Consumer Stocks Advance Pre-Bell Wednesday
Sector Update: Consumer Stocks Advance Pre-Bell Wednesday
Apr 24, 2024
08:58 AM EDT, 04/24/2024 (MT Newswires) -- Consumer stocks were higher pre-bell Wednesday as the Vanguard Consumer Staples Fund (VDC) was flat and the Discretionary Select Sector SPDR Fund (XLY) recently advanced by 1.2%. Tesla (TSLA) was up past 10% in premarket activity after the EV maker posted earnings late Tuesday and revealed plans to lower production costs and introduce...
Interpublic Group Q1 Adjusted Earnings, Revenue Decrease
Interpublic Group Q1 Adjusted Earnings, Revenue Decrease
Apr 24, 2024
09:02 AM EDT, 04/24/2024 (MT Newswires) -- Interpublic Group (IPG) reported Q1 adjusted earnings Wednesday of $0.36 per diluted share, down from $0.38 a year earlier. Analysts polled by Capital IQ expected $0.35. Revenue from the quarter ended March 31 was $2.5 billion, down from $2.52 billion a year earlier. Excluding billable expenses, the company reported revenue of $2.18 billion,...
BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting
BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting
Apr 24, 2024
09:00 AM EDT, 04/24/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) , which is developing immunotherapies to treat cancer, said it will make a presentation on the clinical data of the randomized Phase 2 study evaluating Bria-IMT in patients with advanced metastatic breast cancer at the 2024 American Society of Clinical Oncology annual meeting in Chicago from May 31...
Copyright 2023-2026 - www.financetom.com All Rights Reserved